Terns Pharmaceuticals Balance Sheet (2020-2023) | TERN

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Assets
Current Assets
Cash & Equivalents (Quarter) 11.70M19.59M13.76M74.85M98.83M67.59M64.75M47.70M43.88M16.81M62.98M143.24M169.41M60.75M37.89M
Short-term Investments (Quarter) 96.75M117.50M112.44M118.28M107.39M123.00M124.31M139.88M113.17M204.68M228.71M
Cash & Current Investments (Quarter) 11.70M19.59M13.76M74.85M195.58M185.08M177.20M165.98M151.27M139.81M187.29M283.11M282.58M265.43M266.60M
Current Deferred Tax Assets (Quarter) 2.14M
Prepaid Assets (Quarter) 1.16M2.46M1.79M1.60M0.95M2.84M2.79M3.25M2.07M2.14M2.71M3.85M
Current Assets (Quarter) 90.87M198.04M186.87M178.79M166.93M154.11M142.60M190.54M285.19M299.66M288.31M270.45M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.18M1.02M0.96M0.93M1.05M1.11M0.95M0.81M0.76M0.68M0.59M0.53M
Other Non-Current Assets (Quarter) 0.25M0.17M0.18M0.17M0.09M0.07M0.06M0.05M0.04M0.04M0.04M0.04M
Non-Current Assets (Quarter) 1.42M1.20M1.14M1.10M1.14M2.56M2.26M2.05M1.84M1.62M1.38M1.23M
Assets (Quarter) 92.29M199.24M188.01M179.89M168.07M156.67M144.86M192.59M287.03M301.29M289.70M271.69M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.94M4.25M1.69M1.58M2.13M1.68M0.97M2.09M1.65M2.69M5.54M3.33M
Payables (Quarter) 0.94M4.25M1.69M1.58M2.13M1.68M0.97M2.09M1.65M2.69M5.54M3.33M
Accumulated Expenses (Quarter) 1.49M0.50M0.95M5.31M2.40M0.68M4.49M4.72M6.16M0.83M8.05M3.70M
Other Accumulated Expenses (Quarter) 0.16M0.08M0.13M0.08M0.36M0.27M0.15M0.31M0.18M0.36M0.28M0.39M
Short term Debt (Quarter) 12.88M
Current Leases (Quarter) 0.58M0.59M0.67M0.66M0.66M0.65M0.71M
Total Current Liabilities (Quarter) 22.82M8.38M5.82M6.89M6.82M6.17M6.04M7.48M8.47M12.11M14.24M12.09M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 0.22M0.21M0.19M0.18M0.16M
Preferred Stock Liabilities (Quarter) 73.03M73.03M13.60M30.00M
Operating Leases (Quarter) 1.00M0.85M0.70M0.54M0.39M0.22M0.06M
Other Non-Current Liabilities (Quarter) 0.66M0.65M0.66M0.67M0.79M0.79M0.75M0.71M1.07M1.11M1.09M1.11M
Total Non-Current Liabilities (Quarter) 23.04M8.59M6.01M7.07M6.98M7.17M6.89M8.18M9.01M12.49M14.46M12.15M
Total Liabilities (Quarter) 99.73M109.28M119.81M23.70M9.24M6.67M7.73M7.77M7.95M7.64M8.89M10.08M13.60M15.55M13.26M
Shareholder's Equity
Total Debt (Quarter) 12.88M
Common Equity (Quarter) -99.73M-109.28M-119.81M-117.44M190.00M181.33M172.16M160.30M148.72M137.22M183.69M276.94M287.68M274.15M258.43M
Shareholder's Equity (Quarter) -99.73M-109.28M-119.81M-117.44M190.00M181.33M172.16M160.30M148.72M137.22M183.69M276.94M287.68M274.15M258.43M
Liabilities and Shareholders Equity (Quarter) 92.29M199.24M188.01M179.89M168.07M156.67M144.86M192.59M287.03M301.29M289.70M271.69M
Retained Earnings (Quarter) -131.91M-0.23M-0.17M-167.82M-0.34M-195.85M-209.78M-1.35M-0.82M-263.95M-281.84M-0.84M
Treasury Shares (Quarter) 0.08M0.07M0.07M0.10M0.10M0.13M0.39M0.37M0.36M